A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This is a neoadjuvant study to determine the feasibility and tolerability of 2 weeks of a
very low carbohydrate ketogenic diet in combination with letrozole for patients with early
stage operable ER+disease.